Demant ASWILLF 90 Net Margin % is 3.65% as of Dec. 2025, which is 66% below its 10-year median of 10.61. GuruFocus rates WILLF with a GF Score™ of 90/100 and a GF Value™ of $49.13 (Modestly Undervalued). The stock has 5 warning signs investors should review. Among 817 Medical Devices & Instruments companies, Demant AS ranks better than 63.77% on this metric.
Net margin is calculated as Net Income divided by its Revenue. Demant AS's Net Income for the
six
months ended in Dec. 2025 was $67 Mil. Demant AS's Revenue for the
six
months ended in Dec. 2025 was $1,837 Mil. Therefore, Demant AS's net margin for the quarter that ended in Dec. 2025 was 3.65%.
The historical rank and industry rank for Demant AS's Net Margin % or its related term are showing as below:
WILLF'
s Net Margin % Range Over the Past 10 Years
Min: 6.73 Med: 10.61 Max: 14.04
Current: 6.73
WILLF's Net Margin % is ranked better than 63.77% of 817
companies
in the Medical Devices & Instruments industry
Industry Median: 2.07
vs WILLF: 6.73
Demant AS (OTCPK:WILLF) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
Demant AS Net Margin % Related Terms
Demant AS Net Margin % Historical Data
* Premium members only.
The historical data trend for Demant AS's Net Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Demant AS's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Demant AS Net Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Demant AS's Net Margin % distribution charts can be found below:
* The bar in red indicates where Demant AS's Net Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Demant AS (WILLF) has a Net Margin % of 3.65% as of Dec. 2025. Net margin is the ratio of total net income to net sales. View historical data on Demant AS and its competitors. This is 66% below median its historical median of 10.61. Over the past decade, Demant AS's Net Margin % has ranged from 6.73 to 14.04. According to the industry distribution chart, Demant AS ranks #296 out of 817 companies in the Medical Devices & Instruments industry, placing it in the top 36.2%.
Is Demant AS's Net Margin % too high?
Demant AS's current Net Margin % of 3.65% is 66% below median its 10-year median of 10.61. Over the past 10 years, this metric has ranged from a low of 6.73 to a high of 14.04. The Medical Devices & Instruments industry median Net Margin % is 2.07. Demant AS's value of 3.65% is 76.3% above this industry median. Based on the distribution chart, Demant AS ranks #296 out of 817 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Demant AS has a GF Score™ of 90/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Demant AS's Net Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Demant AS ranks #296 out of 817 companies for Net Margin %. This puts Demant AS in the upper half of its industry. The industry median Net Margin % is 2.07. Demant AS's value of 3.65% is 76.3% above this benchmark. Historically, Demant AS's own Net Margin % has ranged from 6.73 to 14.04 over the past decade. While the company's 10-year median is 10.61 vs. the industry median of 2.07, Demant AS has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Medical Devices & Instruments company?
The median Net Margin % among Medical Devices & Instruments companies is 2.07, based on 817 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Demant AS's current Net Margin % of 3.65% is 76.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Demant AS and its competitors. For the Medical Devices & Instruments industry, the median Net Margin % is 2.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Demant AS's current Net Margin % is 3.65%, which is 66% below median its own 10-year median of 10.61. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Demant AS stock overvalued right now?
Based on GuruFocus' analysis, Demant AS (WILLF) is currently considered Modestly Undervalued. The stock's GF Value™ is $49.13, compared to a current price of $39.12 — trading 20.4% below its estimated fair value. The current Net Margin % is 3.65%, which is 66% below median its 10-year median of 10.61 and 76.3% above the Medical Devices & Instruments industry median of 2.07. Demant AS's overall GF Score™ is 90/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Demant AS (WILLF), the current Net Margin % is 3.65% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Demant AS (WILLF) Overvalued in 2026?
Based on GuruFocus' analysis, Demant AS stock appears to be undervalued.
The current stock price of $39.12 is trading 20.4% below its estimated GF Value™ of $49.13.
GuruFocus considers Demant AS to be Modestly Undervalued.
Key valuation signals for WILLF:
Net Margin %: 3.65% (66% below median its 10-year median of 10.61)
GF Value™: $49.13 vs. price of $39.12 (20.4% below fair value)
Industry Position: 76.3% above the Medical Devices & Instruments median (#296 of 817)
No single metric tells the full story. See the WILLF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Demant is a Denmark-based manufacturer and distributor of hearing solutions, such as hearing aid devices and diagnostic equipment. More than 80% of the company's sales come from North America and Europe.
90GF Score
Get the complete analysis for WILLF
Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
WILLF has been successfully added to your 
